NJ-SPIRENT-COMM
9.2.2021 09:02:10 CET | Business Wire | Press release
Spirent Communications plc (LSE:SPT), the leading provider of test, assurance, and analytics solutions for next-generation devices and networks, today released its second annual 5G outlook report, based on analysis and takeaways from over 600 global 5G engagements in 2020. The “5G 2021: Market Drivers, Insights & Consideration” report provides insights from across the 5G eco-system on the current status of 5G, illustrating the accelerated timetables from service providers in upgrading to 5G standalone (SA) with the new 5G Core, and revealing how 5G is driving new initiatives and sector engagements. The report is available at www.spirent.com/assets/the-spirent-2021-5g-report .
“2020 was certainly a year to remember, not just because of the unprecedented challenges presented by COVID-19, but also because of the rapid development for the telecom industry,” said Spirent Head of 5G Strategy, Steve Douglas. “Telecom is keeping its sights firmly focused on 5G’s future, not in spite of the challenges of the pandemic, but because of them, and our latest report gives an unparalleled view of the current status of 5G and the trends we’re seeing for the year ahead, based on the investments, research, testing and innovation by the leading 5G players.”
The report draws on Spirent’s work with operators, network equipment manufacturers, government, military, and device makers across the globe. It provides an updated, behind-the-scenes view of what’s gone right so far, where challenges persist, and how what was learned during the year is impacting priorities for 2021 and beyond. Key findings from the report include:
- 5G SA core timetables accelerated rapidly: 5G activity surged in 2020 with accelerated timetables from service providers to deliver 5G SA core deployments, following non-standalone’s (NSAs) inability to really wow customers and deliver a solid new revenue proposition. Service Provider engagement increased nearly 50% as Service Assurance integration ramped up, and leading operators accelerated 5G standalone network strategies and new 5G core deployments.
- Because 5G is moving so fast, operators are turning to partners to deliver key elements : Through service contracts, elements that would previously have been delivered inhouse are now being delivered by trusted partners, as operators need to be able to move quickly to keep up with the complexity of 5G and the accelerated timetables.
- 5G is driving new initiatives and engagements: The year saw notable growth in engagements with government, military and academia around 5G experimentation and security initiatives, as governments explore new use cases. Other notable initiatives include Cloud hyperscalers exploring operator edge partnerships, Open RAN being explored in support of supply chain diversity initiatives, and multichannel video programming distributors (MVPDs) accelerating their plans for 5G.
- Automated Assurance and 5G are the new dynamic duo: Whether it was a core network buildout, lab certification, or new service delivered, 5G plus Automated Assurance were the dynamic duo that customers turned to as they sought to continue pushing forward with their 5G plans, with 80% of Spirent’s assurance business focused on 5G work.
- The trend of accelerated timetables is here to stay: While the pandemic has undoubtedly accelerated 5G timetables, it seems likely this accelerated trend is here to stay.
“In many ways, the pandemic has accelerated trends that we hadn’t anticipated gaining steam for at least another couple of years,” said Douglas, “whether fixed wireless access driven by working from home, or automation required to safely conduct field testing with limited personnel. While there were delays, by and large 5G powered ahead and remained in control of its destiny.”
“Spirent provides us with a real-world glimpse into 5G deployments today,” said Patrick Kelly, Founder and Principal Analyst at Appledore Research. “Spirent has a unique perspective in the 5G ecosystem as a leader in test and assurance solutions. The report provides insights into the current status of 5G and what’s coming next, particularly in 5G core, transport, network security, Open RAN progress, and the role of automated assurance.”
Spirent’s “5G 2021: Market Drivers, Insights & Consideration ” report offers a broad view of market-wide 5G challenges, opportunities and plans, and is available as a download at https://www.spirent.com/assets/the-spirent-2021-5g-report .
About Spirent
Spirent Communications plc. (LSE: SPT) is the leading global provider of automated test and assurance solutions for networks, cybersecurity, and positioning. The company provides innovative products, services and managed solutions that address the test, assurance and automation challenges of a new generation of technologies, including 5G, SD-WAN, cloud, autonomous vehicles and beyond. From the lab to the real world, Spirent helps companies deliver on their promise to their customers of a new generation of connected devices and technologies. For more information, please visit www.spirent.com and follow us on LinkedIn , Twitter and Facebook .
View source version on businesswire.com: https://www.businesswire.com/news/home/20210209005179/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
OpenRouter Raises $113 Million CapitalG-led Series B as Weekly Volume Explodes to 25T Tokens26.5.2026 15:15:00 CEST | Press release
NVentures, ServiceNow Ventures, MongoDB Ventures, Snowflake Ventures, Databricks Ventures join CapitalG, a16z, Menlo Ventures, and others in backing the high-growth AI infrastructure startup OpenRouter, the AI model exchange, today announced a $113 million Series B led by Alphabet’s independent growth fund, CapitalG, with participation from investors including NVentures (NVIDIA’s venture capital arm), ServiceNow Ventures, MongoDB Ventures, Snowflake Ventures, Databricks Ventures, alongside existing investors including Andreessen Horowitz and Menlo Ventures. OpenRouter’s volume has surged to 25 trillion tokens per week (100 trillion tokens per month), representing a 5X increase from the 5 trillion tokens processed per week just six months ago. The explosion in token demand illustrates how quickly enterprises are deploying agents and scaling AI across multiple models and providers. OpenRouter’s infrastructure manages and optimizes inference and provides access to 400+ models across leadi
Xsolla Expands Its Community Management Tools for Creators, Community Leaders, and Resellers26.5.2026 15:00:00 CEST | Press release
Xsolla Adds New Features For Creators, Community Leader Experience, And Distinct Channels For Emerging Markets Xsolla, a leading global video game commerce company, today announced three simultaneous expansions of its community management tools and products. As the creator economy continues to reshape how games are discovered and the industry accelerates its shift toward direct-to-consumer commerce, Xsolla is building on its community management tools for creators, community leaders, and emerging markets, and will showcase them at TwitchCon Rotterdam later this month. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260526596720/en/ Graphic: Xsolla The games industry has never had a shortage of people who drive player acquisition, loyalty, and commerce; it's had a shortage of infrastructure that recognizes them. Creators stream it. Community leaders build a culture around it. Local resellers get it into the hands of players in
Biocytogen Launches AI-Powered RenSuper™ Platform and Industry-First Fully Automated Antibody Discovery Infrastructure26.5.2026 14:00:00 CEST | Press release
Biocytogen today announced the launch of RenSuper Workstation, a next-generation AI-powered antibody discovery platform providing off-the-shelf access to a large-scale, experimentally validated library of fully human therapeutic antibody sequences, together with the RenSuper High-Throughput Antibody Manufacturing Automation Center, a fully automated infrastructure designed to accelerate antibody validation and production. Built on Biocytogen’s proprietary RenMice® platforms, RenSuper establishes a closed-loop antibody discovery engine combining in vivo immune repertoires, AI-driven candidate selection, automated experimental validation, and scalable manufacturing infrastructure. The platform supports the discovery and development of monoclonal antibodies, bispecifics, multispecifics, antibody-drug conjugates (ADCs), VHHs, and other advanced therapeutic modalities, significantly reducing the time and risk associated with antibody discovery. RenSuper Workstation: AI-Powered One-Click Tar
ViaLase Announces Global Commercial Introduction of the FLIGHT Procedure26.5.2026 14:00:00 CEST | Press release
First commercial femtosecond laser image-guided, high precision trabeculotomy (FLIGHT) treatments mark a new era in interventional glaucoma; one where precision, safety, and the patient experience define the new standard of care ViaLase, Inc., a commercial stage medical technology company pioneering incision-free, laser-based solutions for glaucoma, today announced the successful completion of the first commercial FLIGHT procedures performed at Centre for Sight in London by Sheraz Daya, MD, and Gus Gazzard, MD, and at Breyer, Kaymak & Klabe Augenchirurgie in Düsseldorf, Germany, by Karsten Klabe, MD. The first commercial FLIGHT procedures were performed using the ViaLuxe® Laser System to deliver an incision-free, image-guided femtosecond laser treatment designed to create precise channels through the trabecular meshwork to restore aqueous outflow and reduce intraocular pressure in patients with open-angle glaucoma. “Centre for Sight has always been committed to bringing meaningful inno
BioIVT to Spotlight ADME-Tox Expertise and Solutions at Summer 2026 Events26.5.2026 14:00:00 CEST | Press release
Company will demonstrate how high-quality, well-characterized biospecimens are critical to the success of both new approach methodologies (NAMs) and traditional studies BioIVT, the leading biospecimen solutions provider and global research partner for drug and diagnostic development, today announced it will showcase its broad portfolio of ADME-Tox solutions and research expertise at several leading industry events, including the 2026 MPS World Summit and the ISSX 16th European Meeting. The MPS World Summit takes place May 26-May 29, 2026, in Washington, D.C. BioIVT colleagues will be available at booth #115 to discuss research questions and needs, including preparation, handling, and utilization of the high-quality tissues and cells needed for microphysiological systems (MPS), as well as conducting ADME studies and bioanalysis. BioIVT offers an extensive range of control and disease state biospecimens, including SPHEROID CERTIFIED™ Hepatocytes as well as advanced HEPATOPAC® co-cultures
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom